Nuevolution AB (publ) announces timing for the release and webcast of the third quarter 2018 interim results
Stockholm, 21 November 2018 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its interim report for the third quarter 2018 on Wednesday, 28 November after 18:00 CET.
On Thursday, 29 November at 9:00 CET, the company’s executive management will host a live video presentation and discussion at Redeye in Stockholm of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained through the following link:
LIVE access on Thursday 29 November at 9:00 CET
Video replay will be available at www.nuevolution.com in the Investors section, and at Redeye.se.
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Johnny Stilou, CFO
Phone: +45 8877 5973
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.
The information was sent for publication, through the agency of the contact persons set out above, on Wednesday 21 November 2018, 18:00 CET.
Nuevolution AB (publ) is listed at Nasdaq in Stockholm, Sweden (ticker: NUE). More information about Nuevolution can be found on: www.nuevolution.com